Skip to main content

How white biotechnology is innovating to advance the global bioeconomy

19th September 2023

Submitted by:

Andrew Warmington

Sona Dadhania, senior technology analyst at IDTechEx, shares some highlights from a new report

The advance of biotechnology is critical to expanding both the bioeconomy, where society uses renewable biological resources to create biobased products and the circular economy. Of the numerous colours of the biotechnology spectrum, in which different colours refer to different applications for biotechnology, white biotechnology stands out as a key technology enabler for the bioeconomy by advancing the industrial production of biobased products through biological systems.

White biotechnology, sometimes called industrial biomanufacturing, is the industrial production and processing of chemicals, materials and energy using living cell factories, like bacteria and yeast. It represents a more sustainable alternative to petroleum-based chemical production: one that not only decreases society’s reliance on fossil fuels but also uses less energy, generates less waste, and potentially creates more environmentally friendly products.

White biotechnology is not particularly new; for example, engineered enzymes for detergents have been produced via white biotechnology since the 1980s. That begs the question: Why is this technology so interesting now?

With improvements in biotechnology tools and processes comes the ability to produce numerous important products, from commodity chemicals to high-performance materials, through white biotechnology. One main technology driver is synthetic biology - the artificial design and engineering of biological systems and living organisms for the purpose of improving applications for industry or research.

Synthetic biology is highly important to industrial biomanufacturing, considering its tools and techniques (i.e. gene editing and strain engineering) that allow white biotechnology to push into new applications. Synthetic biology is by no means the only technology driver for white biotechnology, however.

IDTechEx’s new report ‘White Biotechnology 2024-2034’ also identifies other technology advances enabling the field, such as novel biocatalysts, alternative feedstocks, and cell-free systems. With each technology innovation comes the ability for white biotechnology to better its reach into compelling applications – the chemicals, precursors, additives and materials produced by the fermentation of engineered cell factories.

The range of molecules and compounds that can be biomanufactured is incredibly diverse, with use cases in everything from lubricants to leather, textiles to packaging, adhesives to additives, etc. And this list increases with every technological advance being developed by established and emerging players. The technology innovations of white biotechnology are just one component of the overall market dynamics that are shaping industrial biomanufacturing.

Numerous other factors need to be evaluated to determine the economic viability of certain white biotechnology projects, from internal factors such as process yield, ease of scale, and biocatalyst choice to external factors such as government regulations, crude oil prices, and the green premium. The white biotechnology market needs to be analysed from these perspectives to offer an understanding of the industry’s future trajectory and its role in advancing the global bioeconomy.

Contact:

IDTechEx

[email protected]

www.IDTechEx.com

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington